US · HKPD
Cellyan Biotechnology Co., Ltd
- Sector
- Healthcare · Medical - Pharmaceuticals
- Headquarters
- Yau Tong 999077
- Website
- 9zt.hk
Price · as of 2025-03-31
$0.69
Market cap 7.26M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $402.90 | +58,717.52% |
| Intrinsic Value(DCF) | $0.82 | +19.71% |
| Graham-Dodd Method(GD) | $0.54 | -21.46% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $1.48 | $7.17 | |||
| 2025 | $1.80 | $402.90 | $35.50 | $0.54 | $0.00 |
AI valuation
Our deep-learning model estimates Cellyan Biotechnology Co., Ltd's (HKPD) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $402.90
- Current price
- $0.69
- AI upside
- +58,717.52%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.82
+19.71% upside
Graham-Dodd
$0.54
-21.46% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| HKPD | Cellyan Biotechnology Co.… | $0.69 | 7.26M | +58,718% | +20% | -21% | — | -600.20 | 3.25 | 0.80 | 12.93 | — | 3.32 | 11.89% | 0.65% | -0.13% | -0.59% | 1.05% | -0.30% | 0.48 | 1.35 | 2.99 | 2.65 | 1.35 | -10167.00% | 2172.00% | -18588.00% | 2.55% | 0.20 | 8.22% | 0.00% | 0.00% | 0.00% | 118.21 | 37.68 | 0.77 | 5.37 |
| ARTW | Art's-Way Manufacturing C… | $2.36 | 12.22M | +22,647% | -60% | +54% | -81% | 11.71 | 0.91 | 0.53 | 17.13 | 5.11 | 0.91 | 25.78% | 1.26% | 4.50% | 8.15% | 1.14% | 4.73% | 0.48 | 0.79 | 2.30 | 0.40 | 5.92 | 22895.00% | -622.00% | -18053.00% | -12.64% | -0.14 | -8.37% | 0.00% | 0.00% | 0.01% | 64.08 | -12.09 | 0.81 | 2.82 |
| ATXG | Addentax Group Corp. | $0.34 | 2.93M | +214,572% | +341% | — | +2,378% | -0.88 | 0.21 | 1.08 | -4.00 | -4.47 | 0.21 | 15.17% | -43.46% | -121.84% | -21.32% | -6.25% | -10.04% | 1.03 | -1.58 | 7.54 | 5.92 | -9.73 | 1972.00% | -1888.00% | -21307.00% | 13.76% | 0.21 | 2.13% | 0.00% | 0.00% | 25.77% | -5.00 | 14.70 | 2.17 | 0.30 |
| CRGO | Freightos Limited Ordinar… | $1.32 | 67.7M | +2,456% | -40% | — | — | -3.84 | 1.57 | 2.28 | -2.59 | — | 3.15 | 66.81% | -65.02% | -59.46% | -35.82% | -109.99% | -25.67% | 0.10 | -71.48 | 2.16 | 2.06 | 0.77 | -2391.00% | 2386.00% | -7401.00% | -4.69% | -0.19 | -18.13% | 0.00% | 0.00% | 4.39% | -2.12 | -12.86 | 1.38 | -3.13 |
| JYD | Jayud Global Logistics Li… | $2.80 | 7.35M | +2,539% | +2,493% | — | — | -497.95 | 306.24 | 48.90 | -558.11 | — | 313.48 | -1.98% | -9.22% | -8.77% | -153.76% | -123.07% | -38.98% | 0.27 | -19.97 | 1.46 | 1.04 | 0.26 | -3216.00% | 1354.00% | 10171.00% | -0.36% | -1.01 | -234.05% | 0.00% | 0.00% | 0.14% | -530.12 | -281.44 | 48.88 | 159.41 |
| LSH | Lakeside Holding Limited | $0.66 | 6.19M | +62,370% | +79,702% | — | — | -1.67 | 3.08 | 0.49 | -2.18 | -0.10 | 3.53 | 16.18% | -27.88% | -29.49% | -301.03% | -105.19% | -44.46% | 2.25 | -12.27 | 1.06 | 0.87 | -0.31 | 174000.00% | -287.00% | 494255.00% | -30.85% | -0.27 | -57.37% | 0.00% | 0.00% | 35.05% | -2.06 | -3.77 | 0.57 | 0.09 |
| NCEW | New Century Logistics (BV… | $8.95 | 24.05M | +8,275% | -82% | — | +310% | -8.67 | 17.46 | 2.10 | -8.84 | — | 17.46 | 0.29% | -24.55% | -24.21% | -39.75% | -23.86% | -13.48% | 0.65 | -141.25 | 1.47 | 1.42 | -0.23 | -64545.00% | -8916.00% | -13103.00% | -3.75% | -0.38 | -7.66% | 0.00% | 0.00% | 34.48% | -8.78 | -27.37 | 2.15 | 6.44 |
| PSIG | PS International Group Lt… | $6.19 | 20.1M | +506% | -75% | — | +503% | -2.92 | 1.32 | 0.16 | -1.20 | -0.46 | 1.32 | 4.05% | -6.05% | -5.54% | -41.07% | -207.54% | -16.08% | 0.01 | — | 1.76 | 1.60 | 1.60 | 63889.00% | -3775.00% | 11168.00% | -13.09% | -0.13 | -77.99% | 0.00% | 0.00% | 0.00% | -1.15 | -3.28 | 0.07 | 3.96 |
| TLIH | Ten-League International … | $0.39 | 11.43M | — | — | — | — | — | — | — | — | — | — | 18.22% | 4.78% | 3.22% | 35.71% | 5.17% | 2.75% | 6.05 | 2.95 | 0.70 | 0.32 | 4.25 | -7383.00% | -1963.00% | -5975.00% | — | 0.09 | -20.04% | — | 0.00% | — | — | — | — | — |
| VRME | VerifyMe, Inc. | $0.95 | 11.74M | +6,144% | +77,681% | — | — | -1.99 | 0.74 | 0.31 | -2.82 | -34.74 | 8.82 | 35.78% | -8.57% | -15.80% | -33.62% | -18.86% | -20.80% | 0.22 | -15.96 | 1.50 | 1.46 | 0.24 | 571.00% | -437.00% | -16566.00% | 4.58% | 0.21 | 3.16% | 0.00% | 0.00% | 6.27% | -3.37 | 20.09 | 0.29 | -5.45 |
About Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
- CEO
- Chenyu Liang
- Employees
- 27
- Beta
- 3.63
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.82 ÷ $0.69) − 1 = +19.71% (DCF, example).